{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T11:46:55Z","timestamp":1791028015397,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.clineuro.2010.07.014","type":"journal-article","created":{"date-parts":[[2010,8,20]],"date-time":"2010-08-20T10:39:53Z","timestamp":1282300793000},"page":"870-875","source":"Crossref","is-referenced-by-count":25,"title":["Does reduced [123I]-FP-CIT binding in Huntington's disease suggest pre-synaptic dopaminergic involvement?"],"prefix":"10.1016","volume":"112","author":[{"given":"Josep","family":"Gamez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carles","family":"Lorenzo-Bosquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma","family":"Cuberas-Borr\u00f3s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesc","family":"Carmona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Hern\u00e1ndez-Vara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaquin","family":"Castill\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Castell-Conesa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clineuro.2010.07.014_bib0005","first-page":"37","volume":"vol. 22","year":"1991"},{"key":"10.1016\/j.clineuro.2010.07.014_bib0010","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0140-6736(07)60111-1","article-title":"Huntington's disease","volume":"369","author":"Walker","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.clineuro.2010.07.014_bib0015","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00401-007-0306-6","article-title":"Huntington disease models and human neuropathology: similarities and differences","volume":"115","author":"Vonsattel","year":"2008","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.clineuro.2010.07.014_bib0020","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0168-0102(99)00029-2","article-title":"Extrastriatal dopaminergic innervation of human basal ganglia","volume":"34","author":"Cossette","year":"1999","journal-title":"Neurosci Res"},{"key":"10.1016\/j.clineuro.2010.07.014_bib0025","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/0024-3205(77)90111-4","article-title":"Alterations in dopaminergic receptors in Huntington's disease","volume":"21","author":"Reisine","year":"1977","journal-title":"Life Sci"},{"key":"10.1016\/j.clineuro.2010.07.014_bib0030","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0014-2999(83)90009-2","article-title":"Dopamine D-1 and D-2 receptors in Huntington's disease","volume":"88","author":"Cross","year":"1983","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.clineuro.2010.07.014_bib0035","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/syn.890020511","article-title":"Organization of dopamine D1 and D2 receptor in human striatum: receptor autoradiograhic studies in Huntington's disease and schizophrenia","volume":"2","author":"Joyce","year":"1988","journal-title":"Synapse"},{"key":"10.1016\/j.clineuro.2010.07.014_bib0040","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0014-4886(90)90033-O","article-title":"Nigral dopamine type-1 receptors are reduced in Huntington's disease: a postmortem autoradiographic study using [3H]SCH 23390 and correlation with [3H]forskolin binding","volume":"110","author":"Filloux","year":"1990","journal-title":"Exp Neurol"},{"key":"10.1016\/j.clineuro.2010.07.014_bib0045","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0304-3940(91)90448-3","article-title":"Heterogeneous dopamine receptor changes in early and late Huntington's disease","volume":"132","author":"Richfield","year":"1991","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.clineuro.2010.07.014_bib0050","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/brain\/103.1.179","article-title":"Neurochemical alterations in Huntington's chorea. A study of post-mortem brain tissue","volume":"103","author":"Spokes","year":"1980","journal-title":"Brain"},{"key":"10.1016\/j.clineuro.2010.07.014_bib0055","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1136\/jnnp.44.3.258","article-title":"Homovanilic acid in Huntington's disease and Sydenham's chorea","volume":"44","author":"Cunha","year":"1981","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.clineuro.2010.07.014_bib0060","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/ana.410220318","article-title":"Elevated serotonin and reduced dopamine in subregionally divided Huntington's disease striatum","volume":"22","author":"Kish","year":"1987","journal-title":"Ann Neurol"},{"key":"10.1016\/j.clineuro.2010.07.014_bib0065","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0306-4522(92)90099-N","article-title":"Mesostriatal and mesolimbic dopamine uptake sites are reduced in Parkinson's disease and progressive supranuclear palsy: a quantitative autoradiographic study using [3H] mazindol","volume":"49","author":"Chinaglia","year":"1992","journal-title":"Neuroscience"},{"key":"10.1016\/j.clineuro.2010.07.014_bib0070","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jphysparis.2006.03.004","article-title":"PET imaging of the basal ganglia","volume":"99","author":"Laihinen","year":"2006","journal-title":"J Physiol Paris"},{"key":"10.1016\/j.clineuro.2010.07.014_bib0075","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/ana.410120504","article-title":"Cerebral metabolism and atrophy in Huntington's disease determined by 18FDG and computed tomographic scan","volume":"12","author":"Kuhl","year":"1982","journal-title":"Ann Neurol"},{"key":"10.1016\/j.clineuro.2010.07.014_bib0080","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/mds.870010110","article-title":"Brain energy metabolism and dopaminergic function in Huntington's disease measured in vivo using positron emission tomography","volume":"1","author":"Leenders","year":"1986","journal-title":"Mov Disord"},{"key":"10.1016\/j.clineuro.2010.07.014_bib0085","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/brain\/120.3.503","article-title":"PET study of pre- and post-synaptic dopaminergic markers for the neurodegenerative process in Huntington's disease","volume":"120","author":"Ginovart","year":"1997","journal-title":"Brain"},{"key":"10.1016\/j.clineuro.2010.07.014_bib0090","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1212\/WNL.54.9.1753","article-title":"Decreased striatal monoaminergic terminals in Huntington's disease","volume":"54","author":"Bohnen","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2010.07.014_bib0095","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/00006231-199702000-00011","article-title":"SPET investigations in extrapyramidal diseases using specific ligands","volume":"18","author":"Staffen","year":"1997","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.clineuro.2010.07.014_bib0100","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/1531-8257(200007)15:4<692::AID-MDS1014>3.0.CO;2-V","article-title":"Correlation of Parkinson's disease severity and duration with 123I-FP-CIT SPECT striatal uptake","volume":"15","author":"Benamer","year":"2000","journal-title":"Mov Disord"},{"key":"10.1016\/j.clineuro.2010.07.014_bib0105","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1002\/mds.21710","article-title":"Accuracy of DaTSCAN (123I-Ioflupane) SPECT in diagnosis of patients with clinically uncertain Parkinsonism: 2-years follow-up of an open-label study","volume":"22","author":"Tolosa","year":"2007","journal-title":"Mov Disord"},{"key":"10.1016\/j.clineuro.2010.07.014_bib0110","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/mds.870110204","article-title":"Unified Huntington's Disease Rating Scale: reliability and consistency","volume":"11","year":"1996","journal-title":"Mov Disord"},{"key":"10.1016\/j.clineuro.2010.07.014_bib0115","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1212\/WNL.54.2.452","article-title":"Rate of functional decline in Huntington's disease","volume":"54","author":"Marder","year":"2000","journal-title":"Neurology"},{"issue":"October (10)","key":"10.1016\/j.clineuro.2010.07.014_bib0120","first-page":"BP30","article-title":"European Association of Nuclear Medicine procedure guidelines for brain neurotransmission SPET using (123)I-labelled dopamine D(2) receptor ligands","volume":"29","author":"Tatsch","year":"2002","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.clineuro.2010.07.014_bib0125","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1157\/13059042","article-title":"Differential diagnosis of parkinsonism using dopamine transporters brain SPECT","volume":"122","author":"Lorenzo Bosquet","year":"2004","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.clineuro.2010.07.014_bib0130","first-page":"244","article-title":"Quantitative evaluation of 123I-FP-CIT SPECT: validation of a semiautomated method","volume":"24","author":"Lorenzo Bosquet","year":"2005","journal-title":"Rev Esp Med Nucl"},{"key":"10.1016\/j.clineuro.2010.07.014_bib0135","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1214\/aos\/1013699998","article-title":"The control of the false discovery rate in multiple testing under dependency","volume":"29","author":"Benjamini","year":"2001","journal-title":"Ann Stat"},{"key":"10.1016\/j.clineuro.2010.07.014_bib0140","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1146\/annurev.ne.09.030186.002041","article-title":"Parallel organization of functionally segregated circuits linking basal ganglia and cortex","volume":"9","author":"Alexander","year":"1986","journal-title":"Ann Rev Neurosci"},{"key":"10.1016\/j.clineuro.2010.07.014_bib0145","first-page":"1274","article-title":"Iodine\u2013123-IBZM dopamine D2 receptor and Technetium-99m-HMPAO brain perfusion SPECT in the evaluation of patients with and subjects at risk for Huntington's disease","volume":"34","author":"Ichise","year":"1993","journal-title":"J Nucl Med"},{"key":"10.1016\/j.clineuro.2010.07.014_bib0150","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1093\/brain\/118.3.689","article-title":"Striatal D1 and D2 receptor binding in patients with Huntington's disease and other choreas. A PET study","volume":"118","author":"Turjanski","year":"1995","journal-title":"Brain"},{"key":"10.1016\/j.clineuro.2010.07.014_bib0155","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1093\/brain\/122.12.2353","article-title":"Huntington's disease progression. PET and clinical observations","volume":"122","author":"Andrews","year":"1999","journal-title":"Brain"},{"key":"10.1016\/j.clineuro.2010.07.014_bib0160","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1093\/brain\/awg119","article-title":"Progressive striatal and cortical dopamine receptor dysfunction in Huntington's disease: a PET study","volume":"126","author":"Pavese","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.clineuro.2010.07.014_bib0165","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1471-4159.1992.tb09283.x","article-title":"Increased cerebrospinal fluid dopamine and 3,4-dihydroxyphenylacetic acid levels in Huntington's disease: evidence for an overactive dopaminergic brain transmission","volume":"58","author":"Garrett","year":"1992","journal-title":"J Neurochem"},{"key":"10.1016\/j.clineuro.2010.07.014_bib0170","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/brain\/97.1.457","article-title":"Huntington's chorea. Post-mortem measurement of glutamic acid decarboxylase, choline acetyltransferase and dopamine in basal ganglia","volume":"97","author":"Bird","year":"1974","journal-title":"Brain"},{"key":"10.1016\/j.clineuro.2010.07.014_bib0175","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0006-8993(87)91506-X","article-title":"Tyrosine hydroxylase-like immunoreactivity is distributed in the matrix compartment of normal human and Huntington's disease striatum","volume":"416","author":"Ferrante","year":"1987","journal-title":"Brain Res"},{"key":"10.1016\/j.clineuro.2010.07.014_bib0180","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/0306-4522(88)90249-7","article-title":"Immunocytochemical studies on the basal ganglia and substantia nigra in Parkinson's disease and Huntington's chorea","volume":"25","author":"Waters","year":"1988","journal-title":"Neuroscience"},{"key":"10.1016\/j.clineuro.2010.07.014_bib0185","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1093\/hmg\/ddg218","article-title":"Abnormal association of mutant huntingtin with synaptic vesicles inhibits glutamate release","volume":"12","author":"Li","year":"2003","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.clineuro.2010.07.014_bib0190","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.molmed.2003.08.006","article-title":"Huntington's disease: a synaptopathy?","volume":"9","author":"Li","year":"2003","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.clineuro.2010.07.014_bib0195","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s002590000279","article-title":"Effect of age and gender on dopamine transporter imaging with 123I-FP-CIT SPET in healthy volunteers","volume":"27","author":"Lavalaye","year":"2000","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.clineuro.2010.07.014_bib0200","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1160\/nukmed-0037","article-title":"Equipment-independent reference values for dopamine transporter imaging with 123I-FP-CIT","volume":"46","author":"Koch","year":"2007","journal-title":"Nuklearmedizin"},{"key":"10.1016\/j.clineuro.2010.07.014_bib0205","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/ana.410200305","article-title":"PET scan investigations of Huntington's disease: cerebral metabolic correlates of neurological features and functional decline","volume":"20","author":"Young","year":"1986","journal-title":"Ann Neurol"},{"key":"10.1016\/j.clineuro.2010.07.014_bib0210","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1212\/WNL.54.1.119","article-title":"Bradykinesia in early Huntington's disease","volume":"54","author":"S\u00e1nchez-Pernaute","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2010.07.014_bib0215","first-page":"21","article-title":"Brain imaging and cognitive dysfunctions in Huntington's disease","volume":"31","author":"Montoya","year":"2006","journal-title":"J Psychiatry Neurosci"}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846710002283?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846710002283?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,6]],"date-time":"2021-11-06T18:09:46Z","timestamp":1636222186000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846710002283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":43,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S0303846710002283"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2010.07.014","relation":{},"ISSN":["0303-8467"],"issn-type":[{"value":"0303-8467","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}